The
Kaknäs Tower
|
During this symposium, a first
exchange was established to promote the concepts of pharmacodynamics and
pharmacology of anti-infective drugs in the eraly evaluation or re-evaluation
of anti-infective drugs. The following 4 lectures were delivered by members
of the Industry, Academia, Health Services, and Public Health Authorities.
-
Choosing dosage regimens for
clinical trials (C.W. Norden, American Cyanamid Co., Pearl River, NY, USA)
[Industry]
-
Pharmacodynamics and toxicities
of aminoglycosides and the devlopment of the once-daily regimen concept
(P.M. Tulkens, Catholic University of Louvain, Brussels, Belgium) [Academia]
-
Therapy of systemic fungal infections
by azole antifungals. Difficulties in establishing adequate dosage regimens
(W. Christ, Intitüt. für Arzneimittel des Bundesgesundheisamtes,
Berlin, Germany) [Public Health Authorities]
-
Speeding the development of
antiviral agents through integration of pharmacokinetic-pharmacodynamic
properties (M.N. Dudley, Roger William Medical Ctr, Providence, RI, USA)
[Health Services]
|